Jacob Stanfield, MD
Adult Reconstructive Orthopaedic Surgery · Richland, WANPI 1164740403
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (32.0%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Microport Orthopedics Inc at 43.0% of the total.
Across 70 payments — averaging $196.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Microport Orthopedics Inc$6K
- Stryker$3K
- Orthalign Inc$3K
- Medical Device Business Services, Inc.$963
- Johnson & Johnson$488
- Medacta USA, Inc.$326
- plus $561 from 6 others
What the payments were for
- Consulting fees$4,20031%
- Speaking & faculty fees$4,40032%
- Travel & lodging$1,71612%
- Food & beverage$3,44525%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Microport Orthopedics Inc | 14 | $5,914 |
| Stryker | 33 | $2,823 |
| Orthalign Inc | 5 | $2,687 |
| Medical Device Business Services, Inc. | 4 | $963 |
| Johnson & Johnson | 3 | $488 |
| Medacta USA, Inc. | 4 | $326 |
| Onkos Surgical, Inc. | 2 | $155 |
| Sanara Medtech Inc. | 1 | $122 |
| Naviswiss, Inc. | 1 | $110 |
| Aesculap Implant Systems, LLC | 1 | $99 |
| Skeletal Dynamics Inc | 1 | $54 |
| Zimmer Biomet | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MPO Medial Pivot Knee$5,450
- ORTHALIGN PLUS$2,603
- MAKO$1,646
- GMK SPHERE$191
- CellerateRx$122
- Naviswiss Hip/Knee Navigation$110
- TRIATHLON$105
- ELEOS LIMB SALVAGE SYSTEM$100
How this compares
Too few adult reconstructive orthopaedic surgery providers in Washingtonto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 17 | $414 |
| Oxycodone Hcl | 47 | $272 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $195 |
| Tramadol Hcl | 48 | $113 |
| Methylprednisolone | 15 | $87 |
| Prednisone | 29 | $75 |
| Amoxicillin | 22 | $31 |
| Meloxicam | 12 | $29 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Richland
- David ScottSpokane$671K
- Jason HsuSeattle$287K
- Aric ChristalEdmonds$220K
- Alexander ReichardSpokane$49K
- Nicholas HernandezSeattle$32K
- Cameron EganSeattle$17K
- Joseph DannenbaumTacoma$12K
- Patrick MaherKirkland$10K
- Ronald QuamEverett$7K
- Elyse BrinkmannSeattle$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.